The global progressive multifocal leukoencephalopathy (PML) drug market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Progressive multifocal leukoencephalopathy (PML) is a rare brain infection that affects the substance in the brain that protects nerve cells. The infection gets worse over time and leads to neurological disabilities. The major factor driving the demand for PML drugs is significant prevalence of this infection across the globe.
Get Free Sample link @ https://www.omrglobal.com/request-sample/progressive-multifocal-leukoencephalopathy-drug-market
According to the National Organization for Rare Disorder (NORD), PML is caused by a virus called JC virus (JCV). JCV is found in 85% of the adult population globally. Additionally, PML occurs in approximately one in 200,000 people. Furthermore, in the US and Europe, an estimated 4,000 people develop PML each year. Hence, the rising prevalence of the infection is driving the demand for progressive multifocal leukoencephalopathy drugs.
Some major players in the market include Pfizer, Inc., F. Hoffman – La Roche AG, and Bristol-Myers Squibb Co., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2021, Cellevolve Bio announced a collaboration with Australia-based QIMR Berghofer Medical Research Institute and its cell therapy manufacturing facility Q-Gen Cell Therapeutics. The collaboration was aimed to advance a novel off-the-shelf t-cell therapy in the first randomized cell therapy trial for progressive multifocal leukoencephalopathy (PML).
Full report of Progressive Multifocal Leukoencephalopathy Drug Market available @ https://www.omrglobal.com/industry-reports/progressive-multifocal-leukoencephalopathy-drug-market
Market Coverage
- Segment Covered-
o By Type
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Pfizer, Inc., F. Hoffman – La Roche AG, and Bristol-Myers Squibb Co., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Progressive Multifocal Leukoencephalopathy Drug Market Report by Segment
By Type
- EBT-103
- IKT-01427
- Imatinib Mesylate
- NI-307
- Others
By Application
- Hospital
- Clinic
- Others
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/progressive-multifocal-leukoencephalopathy-drug-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
